NCT04664556 National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
| NCT ID | NCT04664556 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne |
| Condition | Pneumococcal Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2010-12-13 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2010-12-13 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.
Eligibility Criteria
Inclusion Criteria: * Isolate of Streptococcus pneumoniae from at least one blood culture, or pleural fluid, or joint fluid, or cerebrospinal fluid or other normally sterile body site, or if there is a positive blood polymerase chain reaction (PCR). Exclusion Criteria: * Pneumococcal strain not transmetted to National Reference Center for Pneumococci or to Regional Pneumococci Observatory
Contact & Investigator
Levy Corinne
STUDY DIRECTOR
Association Clinique Thérapeutique Infantile du val de Marne
Frequently Asked Questions
Who can join the NCT04664556 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 18 Years, studying Pneumococcal Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04664556 currently recruiting?
Yes, NCT04664556 is actively recruiting participants. Contact the research team at corinne.levy@activ-france.fr for enrollment information.
Where is the NCT04664556 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT04664556 clinical trial?
NCT04664556 is sponsored by Association Clinique Thérapeutique Infantile du val de Marne. The principal investigator is Levy Corinne at Association Clinique Thérapeutique Infantile du val de Marne. The trial plans to enroll 2,500 participants.